You have 4 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenocarcinomas

Showing 1 - 25 of 350
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Colon Trial in Sohag (immunohistochemical staining)

Completed
  • Cancer Colon
  • immunohistochemical staining
  • Sohag, Egypt
    Maisa Hashem Mohammed
Jul 13, 2022

EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

Recruiting
  • EGFR-Mutated Non-Small-Cell Lung Carcinoma
  • Small Cell/Neuroendocrine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Periampullary Adenocarcinoma Trial in Wuhan (laparoscopic pancreaticoduodenectomy, open pancreaticoduodenectomy)

Not yet recruiting
  • Periampullary Adenocarcinoma
  • laparoscopic pancreaticoduodenectomy
  • open pancreaticoduodenectomy
  • Wuhan, Hubei, China
    Department of Biliary and Pancreatic Surgery, Tongji Hospital, A
Mar 15, 2023

Gastric Adenocarcinoma, Pancreas Adenocarcinoma, Gastric Tumor Trial (PT886)

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • (no location specified)
Aug 10, 2022

GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)

Not yet recruiting
  • GastroEsophageal Cancer
    • Lyon, France
      Centre Léon Bérard
    Dec 1, 2022

    Stage IV Lung Adenocarcinoma Trial in United States (Certolizumab, cisplatin, pemetrexed)

    Completed
    • Stage IV Lung Adenocarcinoma
    • Basking Ridge, New Jersey
    • +5 more
    Jan 25, 2023

    Colon Adenocarcinoma, Colorectal Cancer Trial in Orange (drug, combination product, diagnostic test)

    Recruiting
    • Colon Adenocarcinoma
    • Colorectal Cancer
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    May 24, 2022

    Gastrointestinal Tumors Trial in Salt Lake City (Ulixertinib, Hydroxychloroquine)

    Recruiting
    • Gastrointestinal Neoplasms
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Mar 1, 2022

    Adenocarcinomas, Recurrent Gynecological Trial in Singapore (pembrolizumab and lenvatinib)

    Recruiting
    • Adenocarcinomas
    • Recurrent Gynecological
    • pembrolizumab and lenvatinib
    • Singapore, Singapore
      National University Hospital
    Oct 13, 2021

    CINSARC Genomic Signature as Predictor of Resectability of

    Completed
    • Ovarian Adenocarcinoma
    • CINSARC signature
    • Toulouse, France
      Institut Claudius Regaud Institut Universitaire du cancer Toulou
    Dec 22, 2022

    Pancreatic Cancer, Surgery Trial in København, Køge (Propranolol, Placebo)

    Not yet recruiting
    • Pancreatic Cancer
    • Surgery
    • København, Denmark
    • +1 more
    Nov 17, 2023

    Gastric Cancer Trial in Goyang (CKD-702 in combination with irinotecan)

    Recruiting
    • Gastric Cancer
    • CKD-702 in combination with irinotecan
    • Goyang, Gyeonggi, Korea, Republic of
      National Cancer Center
    Feb 20, 2023

    Barrett's Esophagus Without Dysplasia, Barrett Oesophagitis With Dysplasia, Esophageal Adenocarcinoma Trial in Groningen

    Not yet recruiting
    • Barrett's Esophagus Without Dysplasia
    • +2 more
    • Groningen, Netherlands
      University Medical Center Groningen
    Feb 24, 2023

    Gastric and Cardia Adenocarcinomas Trial in Strasbourg (Biopsy)

    Recruiting
    • Gastric and Cardia Adenocarcinomas
    • Biopsy
    • Strasbourg, France
      University Hospital, Strasbourg, france
    Aug 31, 2021

    Genes in Pancreatic Cancer for Better Treatment Selection

    Active, not recruiting
    • Carcinoma, Pancreatic Ductal
    • Molecular Profiling
    • Kingston, Ontario, Canada
    • +3 more
    Jan 25, 2023

    Adenocarcinoma of the Stomach Trial in Goyang (Anti-EGFR antibody in combination with weekly paclitaxel)

    Recruiting
    • Adenocarcinoma of the Stomach
    • Anti-EGFR antibody in combination with weekly paclitaxel
    • Goyang, Gyeonggi, Korea, Republic of
      National Cancer Center
    Nov 29, 2022

    Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Ductal Adenocarcinoma Trial in Baltimore (Stereotactic Body

    Recruiting
    • Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
    • Pancreatic Ductal Adenocarcinoma
    • Stereotactic Body Radiation (SBRT)
    • +3 more
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center
    Jan 28, 2022

    Adenocarcinoma of the Stomach, Adenocarcinoma of the Gastroesophageal Junction Trial in France (Regorafenib and Irinotecan,

    Terminated
    • Adenocarcinoma of the Stomach
    • Adenocarcinoma of the Gastroesophageal Junction
    • Angers, France
    • +26 more
    Jul 26, 2022

    Head Neck Cancers - Salivary Gland Trial in Shanghai (Surufatinib)

    Recruiting
    • Head and Neck Cancers - Salivary Gland
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    May 28, 2021

    Breast Tumors, Breast Cancer, Adenocarcinomas Trial run by the NCI (AdHER2/neu DC Vaccine)

    Completed
    Has Results
    • Breast Neoplasms
    • +3 more
    • Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 12, 2022

    Gastric Cancer, Cancer of Stomach, Gastric Adenocarcinoma Trial in Woodville South (IMU-131, Irinotecan or Paclitaxel,

    Not yet recruiting
    • Gastric Cancer
    • +5 more
    • IMU-131
    • +2 more
    • Woodville South, South Australia, Australia
      The Queen Elizabeth Hospital
    Apr 12, 2022

    Esophagus Cancer, Adenocarcinoma Trial in Copenhagen (uPAR immunohistochemistry)

    Completed
    • Esophagus Cancer, Adenocarcinoma
    • uPAR immunohistochemistry
    • Copenhagen, Region Hovedstaden, Denmark
      Rigshospitalet
    Jun 1, 2021

    Polynuclear Neutrophils' Intra-tumoral Rate and Mutational

    Unknown status
    • Pulmonary Adenocarcinoma
      • (no location specified)
      Feb 16, 2021

      Depending on Surgical Treatment in Adenocarcinomas of

      Completed
      Has Results
      • Esophageal Carcinoma
        • (no location specified)
        Dec 9, 2020

        Microsatellite Stable (MSS) Colorectal Adenocarcinomas, Colorectal Adenocarcinoma Trial in Baltimore (Nivolumab, Relatlimab)

        Recruiting
        • Microsatellite Stable (MSS) Colorectal Adenocarcinomas
        • Colorectal Adenocarcinoma
        • Baltimore, Maryland
          Sidney Kimmel Comprehensive Cancer Center
        Mar 14, 2022